Epinephrine Insurance Coverage Mandate

Current understanding

Michigan SB1032 (103rd Legislature) would amend the Insurance Code (1956 PA 218) by adding sec. 3406ww to require health insurers to cover epinephrine. The mandate would benefit insured patients with severe allergies or anaphylaxis risk by ensuring access to a well-established emergency medication, while imposing a new coverage requirement on health insurers.

Evidence log

• 2026-06-10 — Insurance: health insurers; coverage for prescription inhalers; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406xx.: cross-connection with inhaler-coverage-mandate: Both are drug-specific coverage mandates added to 1956 PA 218 via new sec. 3406-series sections (3406xx for inhalers, 3406ww for epinephrine), reflecting a legislative pattern of mandating insurer coverage for specific life-sustaining prescription drugs. (novelty: 2)
• 2026-06-10 — Insurance: health insurers; coverage for epinephrine; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ww.: cross-connection with insulin-copay-cap: Both are sec. 3406-series amendments to 1956 PA 218 mandating insurer treatment of specific life-critical medications (epinephrine coverage vs. insulin copay cap). (novelty: 2)

Open questions

Related